Skip to content
Home / Companies / CGEN CGE
COMPUGEN LTD (CGEN)
Latest CGEN Insider Trades
About COMPUGEN LTD (CGEN) Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Employees 75
Listed 2000
Exchange XNAS https://www.cgen.com SEC filings for CGEN on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 1 1,875 $5K Grant or award 21 618,500 Option exercise 2 3,750
CGEN Insider Transactions (Form 4) 60 22 Form 4 filings on record, the earliest from Mar 30, 2026, newest first.
Date Insider Transaction Security Shares Price Value Jul 29, 2026 ZL Zurit Levine - Officer Grant or award Ordinary Shares 18,000
Recent CGEN Form 144 Notices of Proposed Sale 2 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Apr 27, 2026 - - - - View on EDGAR Apr 27, 2026 - - -
CGEN Insider Trading - FAQ
What is the latest insider trade for CGEN? COMPUGEN LTD (CGEN) had 13 insider filings in the last 90 days, with the most recent on 2026-07-30. The full record for CGEN runs to 22 Form 4 filings, the earliest from 2026-03-30. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying CGEN stock? No insider purchases of CGEN were filed in the last 90 days.
How many insiders are selling CGEN stock? 1 insider sale of CGEN was filed in the last 90 days, totaling $5K.
Where can I see CGEN SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks CGEN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow CGEN insider buys? Create a free InsiderAlpha account and press Watch on this page to add CGEN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track CGEN insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free EO Eran Ophir - Officer Open-market sale $15K
Apr 14, 2026
Market cap $246.29M
P/E ratio -
Dividend yield -
Average volume 339.4K
52 week high $3.24
52 week low $1.30
Today's high $2.72
Today's low $2.58
Open $2.72
Volume 228.8K
Previous close $2.76
Shares outstanding 94.73M Market cap
$246.29M
75 employees
CGEN Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 1 sale totaling $5K.
Most-Active CGEN Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jul 29, 2026 ZL Zurit Levine - Officer Grant or award Share Option (right to buy) 24,000 $0.00 -
Jul 29, 2026 DS David Silberman - Officer Grant or award Ordinary Shares 19,500 $0.00 -
Jul 29, 2026 DS David Silberman - Officer Grant or award Share Option (right to buy) 26,000 $0.00 -
Jul 29, 2026 EO Eran Ophir - Officer Grant or award Share Option (right to buy) 200,000 $0.00 -
Jul 29, 2026 AC Anat Cohen-Dayag - Director Grant or award Share Option (right to buy) 100,000 $0.00 -
Jul 29, 2026 EP Eran Perry - Director Grant or award Ordinary Shares 7,500 $0.00 -
Jul 29, 2026 EP Eran Perry - Director Grant or award Share Option (right to buy) 10,000 $0.00 -
Jul 29, 2026 PF Pierre Ferre - Officer Grant or award Share Option (right to buy) 70,000 $0.00 -
Jul 29, 2026 RK Russo Sharon Kredo - Officer Grant or award Share Option (right to buy) 24,000 $0.00 -
Jul 29, 2026 MH Mathias Hukkelhoven - Director Grant or award Share Option (right to buy) 10,000 $0.00 -
Jul 29, 2026 GH Gilead Halevy - Director Grant or award Ordinary Shares 7,500 $0.00 -
Jul 29, 2026 GH Gilead Halevy - Director Grant or award Share Option (right to buy) 10,000 $0.00 -
Jul 29, 2026 SZ Sanford S. Zweifach - Director Grant or award Share Option (right to buy) 10,000 $0.00 -
Jul 29, 2026 MM Michelle Mahler - Officer Grant or award Ordinary Shares 13,500 $0.00 -
Jul 29, 2026 MM Michelle Mahler - Officer Grant or award Share Option (right to buy) 18,000 $0.00 -
Jul 9, 2026 ZL Zurit Levine - Officer Option exercise Ordinary Shares 1,875 $0.83 $2K
Jul 9, 2026 ZL Zurit Levine - Officer Open-market sale Ordinary Shares 1,875 $2.50 $5K
Jul 9, 2026 ZL Zurit Levine - Officer Option exercise Share Option (right to buy) 1,875 $0.00 -
Apr 24, 2026 ZL Zurit Levine - Officer Option exercise Ordinary Shares 2,000 $1.15 $2K
Apr 24, 2026 ZL Zurit Levine - Officer Open-market sale Ordinary Shares 2,000 $3.20 $6K
Apr 24, 2026 ZL Zurit Levine - Officer Option exercise Share Option (right to buy) 2,000 $0.00 -
Apr 24, 2026 EO Eran Ophir - Officer Option exercise Ordinary Shares 5,000 $0.83 $4K
Apr 24, 2026 EO Eran Ophir - Officer Open-market sale Ordinary Shares 5,000 $3.20 $16K
Apr 24, 2026 EO Eran Ophir - Officer Option exercise Share Option (right to buy) 5,000 $0.00 -
Apr 14, 2026 EO Eran Ophir - Officer Option exercise Ordinary Shares 5,000 $0.83 $4K
Apr 14, 2026 EO Eran Ophir - Officer Open-market sale Ordinary Shares 5,000 $2.90 $15K
Apr 14, 2026 EO Eran Ophir - Officer Option exercise Share Option (right to buy) 5,000 $0.00 -
Apr 14, 2026 ZL Zurit Levine - Officer Option exercise Ordinary Shares 2,000 $1.15 $2K
Apr 14, 2026 ZL Zurit Levine - Officer Open-market sale Ordinary Shares 2,000 $2.80 $6K
Apr 14, 2026 ZL Zurit Levine - Officer Option exercise Share Option (right to buy) 2,000 $0.00 -
Apr 10, 2026 ZL Zurit Levine - Officer Option exercise Ordinary Shares 1,125 $0.83 $933
Apr 10, 2026 ZL Zurit Levine - Officer Option exercise Ordinary Shares 2,000 $1.15 $2K
Apr 10, 2026 ZL Zurit Levine - Officer Open-market sale Ordinary Shares 3,125 $2.56 $8K
Apr 10, 2026 ZL Zurit Levine - Officer Option exercise Share Option (right to buy) 1,125 $0.00 -
Apr 10, 2026 ZL Zurit Levine - Officer Option exercise Share Option (right to buy) 2,000 $0.00 -
Apr 7, 2026 ZL Zurit Levine - Officer Option exercise Ordinary Shares 2,500 $0.83 $2K
Apr 7, 2026 ZL Zurit Levine - Officer Open-market sale Ordinary Shares 2,500 $2.30 $6K
Apr 8, 2026 ZL Zurit Levine - Officer Option exercise Ordinary Shares 4,375 $0.83 $4K
Apr 8, 2026 ZL Zurit Levine - Officer Option exercise Ordinary Shares 1,000 $1.15 $1K
Apr 8, 2026 ZL Zurit Levine - Officer Open-market sale Ordinary Shares 5,375 $2.42 $13K
Apr 7, 2026 ZL Zurit Levine - Officer Option exercise Share Option (right to buy) 2,500 $0.00 -
Apr 8, 2026 ZL Zurit Levine - Officer Option exercise Share Option (right to buy) 4,375 $0.00 -
Apr 8, 2026 ZL Zurit Levine - Officer Option exercise Share Option (right to buy) 1,000 $0.00 -
Apr 1, 2026 ZL Zurit Levine - Officer Option exercise Ordinary Shares 2,500 $0.83 $2K
Apr 1, 2026 ZL Zurit Levine - Officer Option exercise Ordinary Shares 1,000 $1.15 $1K
Apr 1, 2026 ZL Zurit Levine - Officer Open-market sale Ordinary Shares 3,500 $2.20 $8K
Apr 1, 2026 ZL Zurit Levine - Officer Option exercise Share Option (right to buy) 2,500 $0.00 -
Apr 1, 2026 ZL Zurit Levine - Officer Option exercise Share Option (right to buy) 1,000 $0.00 -
Apr 1, 2026 EO Eran Ophir - Officer Option exercise Ordinary Shares 5,625 $0.83 $5K
Apr 1, 2026 EO Eran Ophir - Officer Open-market sale Ordinary Shares 5,625 $2.21 $12K
Apr 1, 2026 EO Eran Ophir - Officer Option exercise Share Option (right to buy) 5,625 $0.00 -
Mar 26, 2026 ZL Zurit Levine - Officer Option exercise Ordinary Shares 11,875 $0.83 $10K
Mar 26, 2026 ZL Zurit Levine - Officer Open-market sale Ordinary Shares 11,875 $2.04 $24K
Mar 26, 2026 ZL Zurit Levine - Officer Option exercise Share Option (right to buy) 11,875 $0.00 -
CHR 
